Navigation Links
Reportlinker Adds The Outlook for Pharmaceuticals In The Middle East And North Africa To 2015
Date:8/31/2010

NEW YORK, Aug. 31 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

The Outlook for Pharmaceuticals In The Middle East And North Africa To 2015

http://www.reportlinker.com/p0285781/The-Outlook-for-Pharmaceuticals-In-The-Middle-East-And-North-Africa-To-2015.html

Attractive macro-environmental conditions

Political, economic, social and demographic development is making the pharmaceutical markets in the Middle East & North Africa (MENA) region more attractive. The Economist Intelligence Unit (EIU) forecasts that the five MENA markets covered in this collection will represent a combined GDP of US$2.3 trillion in 2015, led by Turkey and Saudi Arabia. Economic development is changing the epidemiological health profile in the region, with the increasing prevalence of communicable diseases. In demographic terms, the population in these five MENA markets is still young and is expected to reach 240.4 million in 2015, headed by Egypt and Turkey. Nevertheless, there is a sizeable elderly population which will demand more healthcare services.

Healthcare development towards privatisation

The population has different levels of expectations in each national healthcare system. The healthcare system in Egypt, for instance, is in a transitory phase, characterised by progress towards privatisation. While access to free healthcare exists, private services are appearing as a result of the decline in the standard of public sector care. There is a need for considerable investment in order to continue the modernisation of programmes and maintain the existing facilities. There are two main areas of reform: primary healthcare and the provision of a national health insurance scheme. In Morocco, the health insurance system is in a transitional phase. Overall, opportunities exist, particularly in Turkey and Egypt, as combined health expenditure in these five markets is projected at US$120.3 billion in 2015.

Increasing pharmaceutical demand

International companies recognise the value and potential of these five MENA pharmaceutical markets. sanofi-aventis, for instance, is the largest pharmaceutical operation in Morocco, whilst GlaxoSmithKline is the leader in Saudi Arabia. Some local producers, such as Hikma from Jordan and SPIMACO from Saudi Arabia, aim to become regional leaders. The projected CAGR for the region is very attractive compared to mature markets or other emerging markets. In fact, the MENA pharmaceutical market is expected to represent a combined valued of US$35.9 billion at retail prices in 2015, including pharmacy and hospital sales. The region is headed by Turkey, followed by Egypt and Saudi Arabia. Local manufacturing production is fragmented and geared towards branded generics, but reliance on imports remains. Biotechnology is still in its infancy.

Highlights from the region

Egypt

Positive economic and demographic factors are expected to drive pharmaceutical market growth. However, healthcare provision is highly fragmented. Regulatory advancements in the internal market will increase manufacturing opportunities, although concerns remain regarding drug price referencing, introduced in 2009. The private pharmacy sector has increased by a high double digit CAGR in recent years, but per capita consumption is still low. The pharmaceutical market is expected to grow by a high CAGR over the next few years, as domestic production is expected to rise and as the healthcare system continues in its transition towards modernisation. There are a number of leading local private producers, some of them involved in biotechnology, which are strengthening their manufacturing capabilities.

Jordan

Although it lacks the oil reserves of many of its neighbours and is relatively poor in comparison, Jordan boasts good links with the West and is a key player on the local political scene. Jordan' s stable economy and rapid population growth are both instrumental in the steady growth of the pharmaceutical market. However, the small population naturally limits market size. The country has a relatively strong level of domestic pharmaceutical production; however, the majority is exported, resulting in a market still dependent on imports. Jordan adheres to WTO rules, in particular the TRIPS agreement. This is exemplified by the recent improvements to, and enforcement of, intellectual property protection.

Morocco

Increasing GDP per capita and health expenditure is expected to encourage drug consumption. The pharmaceutical sector has entered a new phase of development with the adoption of new pharmaceutical legislation, which provides a modern legal framework for the pharmaceutical sector. Although the pharmaceutical market is small in global terms, per capita pharmaceutical spending is comparatively high for an African country. The government aims to cut drug prices and encourage generics consumption in 2010, following a Parliamentary report published in November 2009. There is a well-developed manufacturing industry, but competition from France is increasing; sanofi-aventis is by far the largest pharmaceutical operation, both in terms of production and total sales.

Saudi Arabia

The Saudi pharmaceutical market is the richest in the Gulf region. The private pharmacy sector tends to favour branded pharmaceuticals but is marked by tight price controls. The leading operational companies are GlaxoSmithKline and SPIMACO; the latter is rumoured to be interested in the acquisition of an Egyptian pharmaceutical producer in 2010. The public sector, more genericled, is dependent on oil revenues and is characterised by cost-containment and late payments for tenders. There is little domestic production, therefore the vast majority of the market is provided by imports. However, Saudi Arabia imports a large amount of semi-finished medicaments, some of which are then re-labelled, repackaged and exported. In terms of research, the Ministry of Commerce & Industry has identified biotechnology as an area of investment in the country.

Turkey

Turkey is the largest MENA pharmaceutical market, due to its sizeable population and large GDP. The legal environment, however, will pose challenges in the forecast period. Turkey' s negotiations on EU accession continue but the country is not expected to become a member state until at least 2015. In this context, Turkey has sought to align its national pharmaceutical legislation with that of the EU, but the harmonisation process is still incomplete. The market is expected to grow by a moderately high CAGR in US dollar terms between 2010 and 2015; however, the government' s ongoing healthcare reforms may slightly temper the rate of growth, particularly with regards to price controls. Overall, the market will continue to be driven by import growth and generics consumption

Egypt: World Pharmaceutical Market Q2 2010

EXECUTIVE SUMMARY

Snapshot: Strategic Espicom Analysis

Snapshot: Key Data Projections

MACROENVIRONMENT

POLITICAL

ECONOMIC Projections

LEGAL Intellectual Property Rights

DEMOGRAPHIC Projections

Demographic Indicators

EPIDEMIOLOGY

DISEASE BURDEN

DISEASE PREVALENCE Communicable Diseases

Non-Communicable Diseases Cancer

HEALTHCARE - ACCOMPANYING HEALTH STATISTICS

ORGANISATION Government Sector (Ministry of Health)

Public Sector

Private Sector

Healthcare Reforms Healthcare Sector Reform Project

EXPENDITURE Projections

Health Insurance Health Insurance Bill

Health Insurance Systems Development Project

Health Insurance Beneficiaries

INFRASTRUCTURE

SERVICES Hospital Inpatient Services

WORKFORCE Projections

REGULATORY AFFAIRS

PHARMACEUTICAL REGISTRATION

NATIONAL DRUGS POLICY Essential Drugs List

PRICING & REIMBURSEMENT

PRICING New Drug Pricing Decree

DISTRIBUTION CHANNELS

WHOLESALING Public Wholesalers El-Gomhouria

El-Masriya

Private Wholesalers Multipharma

RETAILING Pharmacy Chains El-Ezaby Pharmacy Chain

Misr Pharmacies

Seif Pharmacies

MARKET ANALYSIS

SIZE Projections

Current Size

Current Structure

PRODUCT DEVELOPMENT

MANUFACTURING

TRADE Exports

Imports

Balance of Trade

COMPETITION

TRADE ASSOCIATIONS AUPAM

FEI

TRADE FAIR

COMPANY INTELLIGENCE Public Sector Producers ADCO

Alexandria

CID

El-Nasr

Kahira

Memphis

Misr

Nile

Local Private Producers ACDIMA

EIPICO

Minapharm

MultiApex

October Pharma

Pharco Corporation

SEDICO

Foreign Private Producers AstraZeneca

GlaxoSmithKline

Hikma

Novartis

sanofi-aventis

Competitive Strategies

OTC PHARMACEUTICALS

GENERIC PHARMACEUTICALS

PRICING New Drug Pricing Decree

MARKET

BIOLOGICS & BIOSIMILARS

REGULATION

DISTRIBUTION

PRODUCT DEVELOPMENT

COMPETITION Company Intelligence Arab Company for Medical Appliances

EIPICO

Nile

Rhein Minapharm Biogenetics

CONCLUSIONS: OPPORTUNITIES & CHALLENGES

Strategic Espicom Analysis MACROENVIRONMENT

EPIDEMIOLOGY

HEALTHCARE

REGULATORY AFFAIRS

PRICING & REIMBURSEMENT

DISTRIBUTION CHANNELS

MARKET

COMPETITION

OTC PHARMACEUTICALS

GENERIC PHARMACEUTICALS

BIOLOGICS & BIOSIMILARS

Radar Analysis

SWOT Analysis

DIRECTORY

GOVERNMENT ORGANISATIONS

PRODUCERS Local Public Holding

Local Private Producers

Foreign Private Producers

TRADE ASSOCIATIONS

LIST OF TABLES

Espicom Analysis of the Pharmaceutical Market, 2010 Summary of Key Data Projections, 2010-2015 Political Landscape, 2010 Regional Comparison of Projected Economies, 2015 Projected Economy, 2010-2015 Regional Comparison of Projected Demographics, 2015 Projected Demographics, 2010-2015 Population by Governorate, 2002/2006 Demographic Indicators, 2000-2007 Regional Comparison of Projected Health Expenditure, 2015 Health Expenditure, 2010-2015 Beneficiaries from Health Insurance System, 1999-2008 Hospital Beds, 2000-2009 Public & Village Hospitals and Rural Health Units, 2000-2008 Regional Comparison of Projected Physicians, 2015 Projected Physicians, 2010-2015 Medical Personnel, 2000-2008 Regional Comparison of Projected Pharmaceutical Markets, 2015 Projected Pharmaceutical Market, 2010-2015 Pharmaceutical Market, 2010 Pharmacy Sector by Origin, 2004/2008 (LE Million) Pharmacy Sector by Origin, 2004/2008 (Million Units) Pharmaceutical Producers, 2006 Pharmaceutical Exports by Category, 2004-2008 (US$000s) Pharmaceutical Exports by Country/Region, 2008 (US$000s) Pharmaceutical Imports by Category, 2004-2008 (US$000s) Imports of Raw Materials by Country/Region, 2008 (US$000s) Imports of Antisera & Vaccines by Country/Region, 2008 (US$000s) Imports of Medicaments by Country/Region, 2008 (US$000s) Pharmaceutical Balance of Trade, 2004-2008 (US$000s) HOLDIPHARMA' s Affiliated Companies, 2010 HOLDIPHARMA' s Joint-Ventures, 2010 HOLDIPHARMA Affiliates' Combined Financial Indicators, FY 2006/2007-FY2008/2009 Pharco Corporation' s Indicators by Subsidiary, 2009 Espicom Analysis of the Pharmaceutical Market, 2010 SWOT Analysis of the Pharmaceutical Market, 2010

LIST OF CHARTS

Regional Comparison of Projected Pharmaceutical Markets, 2015 Pharmaceutical Exports, 2003-2008 (US$ Millions) Pharmaceutical Imports, 2003-2008 (US$ Millions) Pharmaceutical Imports by Country/Region, 2008 (%) Pharmaceutical Balance of Trade, 2003-2008 (US$ Millions)

Radar Graph of the Pharmaceutical Market, 2010

Jordan: World Pharmaceutical Market Q2 2010

EXECUTIVE SUMMARY

Snapshot: Strategic Espicom Analysis

Snapshot: Key Data Projections

MACROENVIRONMENT

POLITICAL

ECONOMIC Projections

LEGAL

DEMOGRAPHIC Projections

Demographic Indicators Births

Deaths

Infant Deaths

Life Expectancy at Birth

EPIDEMIOLOGY

DISEASE BURDEN Leading Causes of Mortality

DISEASE PREVALENCE Communicable Diseases HIV/AIDS

Non-Communicable Diseases Cancer Incidence

HEALTHCARE - ACCOMPANYING HEALTH STATISTICS

ORGANISATION

EXPENDITURE Projections

Latest Figures

INFRASTRUCTURE Hospital Infrastructure

Ambulatory Infrastructure

SERVICES Hospital Inpatient Services

Outpatient Services

WORKFORCE Projections

Physicians

Nurses

Dentists

Pharmacists

REGULATORY AFFAIRS

NATIONAL AUTHORITY Ministry of Health

MARKETING REGISTRATION National Procedures

IMPORT REGULATIONS

PRICING & REIMBURSEMENT

DISTRIBUTION CHANNELS

DRUG RETAILING

MARKET ANALYSIS

SIZE Projections

Current Size

Current Structure

PRODUCT DEVELOPMENT

MANUFACTURING Domestic Production

TRADE Exports

Imports

Balance of Trade

COMPETITION

TRADE ASSOCIATION Jordanian Association of Manufacturers of Pharmaceuticals & Medical Appliances

TRADE FAIRS Phar/MedExpo 2010

AUPAM Conference - Creating New Business Relationships

COMPANY INTELLIGENCE Domestic Producers Arab Centre for Pharmaceuticals and Chemicals

Dar Al Dawa

Hayat Pharmaceutical Industries

Hikma Pharmaceuticals

Jordanian Pharmaceuticals Manufacturing

Jordan River Pharmaceutical Industries

Jordan Sweden Medical and Sterilisation Company

Middle East Pharmaceutical Manufacturing Company

Pharma International

United Pharmaceutical Manufacturing

BIOLOGICS & BIOSIMILARS

PRODUCT DEVELOPMENT

COMPETITION Company Intelligence Al-Kindi Pharmaceutical Industries

AraGen Biotechnology

MONOJO

Competitive Strategies

CONCLUSIONS: OPPORTUNITIES & CHALLENGES

Strategic Espicom Analysis MACROENVIRONMENT

EPIDEMIOLOGY

HEALTHCARE

REGULATORY AFFAIRS

PRICING & REIMBURSEMENT

DISTRIBUTION CHANNELS

MARKET

COMPETITION

OTC PHARMACEUTICALS

GENERIC PHARMACEUTICALS

BIOLOGICS & BIOSIMILARS

Radar Analysis

SWOT Analysis

DIRECTORY

GOVERNMENT ORGANISATIONS

PHARMACEUTICAL PRODUCERS Domestic Producers

Biotechnology Companies

TRADE ORGANISATION

LIST OF TABLES

Espicom Analysis of the Pharmaceutical Market, 2010 Key Data Projections, 2010-2015 Political Landscape, 2010 Regional Comparison of Projected Economies, 2015 Projected Economy, 2010-2015 Regional Comparison of Projected Demographics, 2015 Projected Demographics, 2010-2015 Population by Governorate, 2008 (000s) Summary of Demographic Indicators, 2008/2010 Demographic Indicators, 2003-2008 Notifiable Communicable Diseases & Conditions, 2004-2008 HIV/AIDS Patients, 1986-2008 Cancer Incidence by Sex, 2007 Regional Comparison of Projected Health Expenditure, 2015 Projected Health Expenditure, 2010-2015 Ministry of Health (MoH) Budget, 2004-2008 (JOD Millions) Hospitals & Beds, 2006 Hospital Beds by Sector, 2002-2006 MoH Health Centres, 2004-2008 MoH Hospital Activity, 2000-2008 Primary Healthcare Visits by Condition, 2004/2006 Regional Comparison of Projected Physicians, 2015 Projected Physicians, 2010-2015 Physicians by Sector, 2008 Nursing Staff by Category & Sector, 2008 Dentists by Sector, 2008 Pharmacists by Sector, 2008 Pharmacies, 2001-2008 Pharmacies by Governorate, 2005-2008 Regional Comparison of Projected Pharmaceutical Markets, 2015 Projected Pharmaceutical Market, 2010-2015 Pharmaceutical Market, 2010 Expenditure on Pharmaceuticals, 2000-2007 (JOD) Pharmaceutical Exports by Category, 2004-2008 (US$000s) Leading Destinations of Pharmaceuticals, 2008 (US$000s) Pharmaceutical Imports by Category, 2004-2008 (US$000s) Leading Suppliers of Raw Materials, 2008 (US$000s) Leading Suppliers of Antisera & Vaccines, 2008 (US$000s) Leading Suppliers of Medicaments, 2008 (US$000s) Balance of Pharmaceutical Trade, 2004-2008 (US$000s) Sales from 10 Jordanian Pharmaceutical Companies, 2007-2008 (JOD Millions) Members of JAPM, 2010 Hikma Pharmaceuticals' Mid-Year Results, 2009 (US$ Millions) Hikma Pharmaceuticals' Results, 2008 (US$ Millions) Hikma Pharmaceuticals' Results by Region, 2008 (US$ millions) Espicom Analysis of the Pharmaceutical Market, 2010 SWOT Analysis of the Pharmaceutical Market, 2010

LIST OF CHARTS

Regional Comparison of Projected Pharmaceutical Markets, 2015 Pharmaceutical Exports, 2000-2008 (US$ Millions) Change in Pharmaceutical Exports, 2001-2008 (%) Pharmaceutical Exports by Country/Region, 2008 (%) Pharmaceutical Imports, 2000-2008 (US$ Millions) Change in Pharmaceutical Imports, 2001-2008 (%) Pharmaceutical Imports by Country/Region, 2008 (%) Pharmaceutical Balance of Trade, 2000-2008 (US$ Millions) Radar Graph of the Pharmaceutical Market, 2010

Morocco: World Pharmaceutical Market Q2 2010

EXECUTIVE SUMMARY

Snapshot: Strategic Espicom Analysis

Snapshot: Key Data Projections

MACROENVIRONMENT

POLITICAL

ECONOMIC Projections

LEGAL Intellectual Property Rights

DEMOGRAPHIC Projections

Demographic Indicators Birth Rate

Death Rate

Infant Mortality

Maternal Mortality

Life Expectancy at Birth

EPIDEMIOLOGY

DISEASE BURDEN Leading Causes of Mortality

DISEASE PREVALENCE Communicable Diseases STIs & HIV/AIDS

Non-Communicable Diseases

HEALTHCARE - ACCOMPANYING HEALTH STATISTICS

ORGANISATION Five Year Action Plan for the Health Sector (2008-2012)

New Planning Tools

EXPENDITURE Projections

Latest Figures Ministry of Health Budget, 2009

Health Insurance Compulsory Health Insurance Scheme

RAMED Scheme

INFRASTRUCTURE Hospital Infrastructure Capital Investment Programme, 2009

Ambulatory Infrastructure Public Ambulatory Infrastructure

Private Ambulatory Infrastructure

SERVICES Hospital Inpatient Services

WORKFORCE Projections

Latest Figures Physicians

Dentists

Nurses

Pharmacists

REGULATORY AFFAIRS

Pharmaceutical Regulation New Pharmaceutical Law

PRICING & REIMBURSEMENT

PRICING New Pharmaceutical Pricing System

Parliamentary Drug Pricing Report

Pharmaceutical Pricing System

Pharmaceutical Cost Structure

REIMBURSEMENT

DISTRIBUTION CHANNELS

MOH SUPPLIES DIVISION

WHOLESALING Cooper Maroc

Sophasud

RETAILING

MARKET ANALYSIS

SIZE Projections

Current Size

Current Structure Private Pharmacy Sales

CNOPS Pharmacy Sales

PRODUCT DEVELOPMENT

MANUFACTURING

TRADE Exports

Imports

Balance of Trade

COMPETITION

TRADE ASSOCIATIONS AMIP

MIS

TRADE FAIR Medical Expo

COMPANY INTELLIGENCE Local Manufacturers Afric-Phar

Bottu

Cooper Maroc

Laboratoire Galenica

Iberma

Laprophan

Pharmaceutical Institute

Polymedic

Promopharm

Sothema

Multinational Manufacturers Bayer Pharma Maroc

GlaxoSmithKline

Pfizer

sanofi-aventis

Servier

GENERIC PHARMACEUTICALS

PRICING New Pharmaceutical Pricing System

MARKET

BIOLOGICS & BIOSIMILARS

REGULATORY AFFAIRS Regulation of Biosimilars

MARKET SIZE Biosimilar Market

CONCLUSIONS: OPPORTUNITIES & CHALLENGES

Strategic Espicom Analysis MACROENVIRONMENT

EPIDEMIOLOGY

HEALTHCARE

REGULATORY AFFAIRS

PRICING & REIMBURSEMENT

DISTRIBUTION CHANNELS

MARKET

COMPETITION

OTC PHARMACEUTICALS

GENERIC PHARMACEUTICALS

BIOLOGICS & BIOSIMILARS

Radar Analysis

SWOT Analysis

DIRECTORY

GOVERNMENT ORGANISATIONS

PRODUCERS Local Producers

Multinational Producers

TRADE ASSOCIATIONS

LIST OF TABLES

Espicom Analysis of the Pharmaceutical Market, 2010 Summary of Key Data Projections, 2010-2015 Political Landscape, 2010 Regional Comparison of Projected Economies, 2015 Projected Economy, 2010-2015 Regional Comparison of Projected Demographics, 2015 Projected Demographics, 2010-2015 Principal Demographic Indicators, 2002-2007 Reported Communicable Diseases, 2000-2007 Regional Comparison of Projected Health Expenditure, 2015 Projected Health Expenditure, 2010-2015 Health Expenditure, 2001-2008 Hospitals & Beds, 2007 Outpatient Facilities in the Public Sector, 2000-2007 Outpatient Facilities in the Private Sector, 2003-2007 Public Hospital Activity, 2001-2007 Activity of Public Hospital Surgical & Maternity Units, 2001-2007 University Hospital Activity, 2007 Regional Comparison of Projected Physicians, 2015 Projected Physicians, 2010-2015 Medical Personnel, 2000-2007 Retail Pharmacies by Region, 2006-2007 Regional Comparison of Projected Pharmaceutical Markets, 2015 Pharmaceutical Market Projections, 2010-2015 Pharmaceutical Market, 2010 Pharmaceutical Market by Sector at Retail Prices, 2008 Private Pharmacy Sales at Manufacturers' Prices, 1998-2009 Private Pharmacy Sales at Manufacturers' Prices, 1998-2009 (DH Millions) CNOPS Pharmacy Sales, 2000-2008 CNOPS Branded & Generic Pharmacy Sales, 2006-2008 (DH Million) Production Units & Direct Employees, 1965-2008 Pharmaceutical Production, 1999-2005 Pharmaceutical Production by Type, 2003/2005 Key Figures for Pharmaceutical Producers, 2003-2005 Pharmaceutical Exports by Category, 2004-2008 (US$ Million) Pharmaceutical Exports by Country/Region, 2008 (US$000s) Pharmaceutical Imports by Category, 2004-2008 (US$000s) Imports of Raw Materials by Country/Region, 2008 (US$000s) Imports of Antisera & Vaccines by Country/Region, 2008 (US$000s) Imports of Medicaments by Country/Region, 2008 (US$000s) Balance of Pharmaceutical Trade, 2004-2008 (US$000s) Members of AMIP, 2010 Members of MIS, 2010 Espicom Analysis of the Pharmaceutical Market, 2010 SWOT Analysis of the Pharmaceutical Market, 2010

LIST OF CHARTS

Ministry of Health' s Budget by Sector, 1995-2009 (DH 000s) Regional Comparison of Projected Pharmaceutical Markets, 2015 Private Pharmacy Sales Value by Principal Therapeutic Categories, 2007 (%) Private Pharmacy Sales Volume by Principal Therapeutic Categories, 2007 (%) Pharmaceutical Exports, 1997-2008 Pharmaceutical Imports, 1997-2008 Pharmaceutical Imports by Leading Country/Region, 2008 (%) Balance of Pharmaceutical Trade, 2000-2008 (US$ Millions) Branded & Generic Pharmacy Sales Volume, 2001-2007 Radar Graph of the Pharmaceutical Market, 2010

Saudi Arabia: Pharmaceutical Market Intelligence Report Quarter II 2010

EXECUTIVE SUMMARY

Pharmaceutical Market Analysis

Size

Market Structure Pharmacy Sector

Generics Sector

Projections & Outlook

Imports

Domestic Manufacturing Local Pharmaceutical Manufacturers Jamjoom

Riyadh Pharma

SAJAPHCO

SPIMACO

Tabuk

Foreign Pharmaceutical Manufacturers GlaxoSmithKline

Hikma

Biotechnology Manufacturers Jeddah BioCity

Stem Cell Research

Exports

Balance of Trade

Research & Development

Pharmaceutical Regulatory Analysis

Pharmaceutical Regulation

Pricing & Reimbursement Price Cuts

GCC Plans to Standardise Price of Medicines

Intellectual Property Rights Background

USTR Position

Pharmaceutical Distribution

Drug Wholesaling Abdulrehman Algosaibi

Arabian Medical Hospital Supply Company

Arabian Medicare

Banaja

Tamer Group

Drug Retailing

Healthcare Analysis

Demographics Population

Demographic Indicators Birth Rate

Death Rate

Infant Mortality

Life Expectancy at Birth

Public Health Causes of Death

Communicable Diseases

Non-communicable Diseases

To order this report:

Pharmaceutical Industry: The Outlook for Pharmaceuticals In The Middle East And North Africa To 2015

Pharmaceutical Business News

More Market Research Report

Check our Company Profile, SWOT and Revenue Analysis!

CONTACT:

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. Reportlinker Adds Epigenetics: Current and future applications that are driving novel drug discovery
2. Reportlinker Adds Clinical Laboratory Testing Volume 1: Reagents and Instruments
3. Reportlinker Adds Portable and Transport Ventilator Market Shares, Strategies, and Forecasts, Worldwide, 2010 to 2016
4. Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions
5. Reportlinker Adds Strategic Analysis of End-user Preferences in the U.S. Stem Cell Research Tools Markets
6. Reportlinker Adds Production and Market of Xylose in China
7. Reportlinker Adds Advances in Large Scale BioManufacturing and Scale-Up Production, 2nd ED
8. Reportlinker Adds European Markets for Small Joint Reconstructive Devices 2010 (15 Countries)
9. Reportlinker Adds Japanese Market for Small Joint Reconstructive Devices 2010
10. Reportlinker Adds Effective Social Media Marketing Strategies for Pharmaceutical Market
11. Reportlinker Adds Wireless Medical Technologies 2007-2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... Endo International plc (NASDAQ: ENDP ) (TSX: ENL) ... former president of Allergan, Inc. and current CEO of Chase ... of TPG Capital, to its Board of Directors. The appointments ... "Endo recently embarked on a search for new Board members ... Doug and Todd are experienced leaders, and we are extremely ...
(Date:5/5/2016)... Grand Cayman , May 5, 2016 Progra ... successful trial of Oxitec , s mosquito ... Aedes aegypti by 96 % ... (MRCU) announced a new plan to fight wild Aedes aegypti, the ... these diseases on the island of Grand Cayman .  MRCU, ...
(Date:5/5/2016)... May 5, 2016 Research and ... PET Imaging in the USA"  report to their offering.  ... information on the current Positron Emission Tomography (PET) scanner ... market. Along with the current known number ... USA , the report also contains a detailed ...
Breaking Medicine Technology:
(Date:5/6/2016)... ... 2016 , ... A wide variety of national pet product manufacturers, companies and brands will gather ... Wednesday, May 18 from noon to 8 p.m. at New York City’s Roger Smith Hotel. ... established home, garden, outdoor and safety pet products in today’s marketplace. , Petrend ...
(Date:5/6/2016)... ... May 06, 2016 , ... Logically, spring weather, with its moderate humidity ... is too cold, dry or hot, water on the eye surface can evaporate, creating ... the surrounding air. There’s only one problem, according to radio show and water advocate ...
(Date:5/6/2016)... ... , ... Canadian author Mark Black is a speaker, author, and life strategy coach ... world … with the help of his publisher Strategic Book Group and its subsidiary ... hospital bed waiting for a miracle: He needed a heart and double-lung transplant. From this ...
(Date:5/6/2016)... ... ... Overseer at The House of Yahweh, has written a new article this week meant to ... stop cancer. Yisrayl says there are too many suffering and dying from the disease to ... pay close attention and take action. The Pastor says that the root cause of all ...
(Date:5/6/2016)... , ... May 06, 2016 , ... ... and David Konur, CEO of Cardiovascular Institute of the South announced today that ... performing a live case of an Intravascular Ultrasound Guided Coronary Atherectomy. ...
Breaking Medicine News(10 mins):